Ming-shiu Hung

Miaoli, TNQ 35053, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

A modular microfluidic chip unit for multiple-organ-on-chip platform integration and drug screening.

A modular microfluidic chip unit for multiple-organ-on-chip platform integration and drug screening.

Journal: The Analyst
Published: July 08, 2026

Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Journal: EMBO molecular medicine
Published: April 03, 2025

Corrigendum to "Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin" [Biochem. Pharmacol. 215 (2023) 115688].

Corrigendum to "Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin" [Biochem. Pharmacol. 215 (2023) 115688].

Journal: Biochemical pharmacology
Published: January 18, 2025

Decrypting orphan GPCR drug discovery via multitask learning.

Decrypting orphan GPCR drug discovery via multitask learning.

Journal: Journal of cheminformatics
Published: September 28, 2023

Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Journal: EMBO molecular medicine
Published: September 01, 2023

Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin.

Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin.

Journal: Biochemical pharmacology
Published: March 27, 2023

Modulating the affinity and signaling bias of cannabinoid receptor 1 antagonists.

Modulating the affinity and signaling bias of cannabinoid receptor 1 antagonists.

Journal: Bioorganic chemistry
Published: March 19, 2022

Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design.

Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design.

Journal: European journal of medicinal chemistry
Published: October 03, 2021

Correction to Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.

Correction to Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.

Journal: Journal of medicinal chemistry
Published: June 24, 2020

Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.

Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.

Journal: Journal of medicinal chemistry
Published: January 22, 2020

A structure-function approach identifies L-PGDS as a mediator responsible for glucocorticoid-induced leptin expression in adipocytes.

A structure-function approach identifies L-PGDS as a mediator responsible for glucocorticoid-induced leptin expression in adipocytes.

Journal: Biochemical pharmacology
Published: March 02, 2019

Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray.

Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 24, 2018
Showing 1-12 of 22

Last Updated: 09/26/2026